Transgene S.A. (0OCQ.L) LSE
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 138.55M |
| Enterprise Value | 133.95M |
| P/E Ratio | -3.11 |
| PEG Ratio | -0.29 |
| Price/Sales Ratio | 1,641.1 |
| Price/Book Ratio | 1.06 |
| Enterprise/Revenue | 1,607.54 |
| Enterprise/EBITDA | -5.54 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -273.9 |
| Operating Margin | -299.78 |
AD
Management Effectiveness
| Return On Assets | -0.27 |
| Return On Equity | -0.64 |
Income Statement
| Revenue | 137,000 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -39.77M |
| Net Income | -37.52M |
| Diluted EPS | -0.26 |
Balance Sheet
| Total Cash | 111.86M |
| Total Cash/Share | 0.7 |
| Total Debt | 2.06M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 9.62 |
| Book Value Per Share | 0.76 |
Price History
| 52-Week Change | -14.57 |
| 52-Week High | 2.3 |
| 52-Week Low | 0.8 |
| Moving Average 50 Days | 1.58 |
| Moving Average 200 Days | 1.72 |
Statistics
| Average Volume | 520 |
| Shares Outstanding | 144.2M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 40:39 |
| Last Split Date | June 20, 2019 |
AD
